- Home
- CLLS vs OZ Comparison
CLLS vs OZ Comparison
Compare CLLS & OZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- OZ
- Stock Information
- Founded
- CLLS 1999
- OZ 2020
- Country
- CLLS France
- OZ United States
- Employees
- CLLS N/A
- OZ N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- OZ
- Sector
- CLLS Health Care
- OZ
- Exchange
- CLLS Nasdaq
- OZ Nasdaq
- Market Cap
- CLLS 143.4M
- OZ 239.8M
- IPO Year
- CLLS 2007
- OZ N/A
- Fundamental
- Price
- CLLS $1.58
- OZ N/A
- Analyst Decision
- CLLS Buy
- OZ
- Analyst Count
- CLLS 1
- OZ 0
- Target Price
- CLLS $4.00
- OZ N/A
- AVG Volume (30 Days)
- CLLS 54.7K
- OZ 1.7K
- Earning Date
- CLLS 08-05-2025
- OZ 01-01-0001
- Dividend Yield
- CLLS N/A
- OZ N/A
- EPS Growth
- CLLS N/A
- OZ N/A
- EPS
- CLLS N/A
- OZ N/A
- Revenue
- CLLS $54,747,000.00
- OZ $4,077,000.00
- Revenue This Year
- CLLS $48.52
- OZ N/A
- Revenue Next Year
- CLLS $5.17
- OZ N/A
- P/E Ratio
- CLLS N/A
- OZ N/A
- Revenue Growth
- CLLS 351.26
- OZ 94.70
- 52 Week Low
- CLLS $1.10
- OZ $56.77
- 52 Week High
- CLLS $2.43
- OZ $82.89
- Technical
- Relative Strength Index (RSI)
- CLLS 64.58
- OZ 51.30
- Support Level
- CLLS $1.41
- OZ $65.58
- Resistance Level
- CLLS $1.65
- OZ $66.24
- Average True Range (ATR)
- CLLS 0.10
- OZ 0.42
- MACD
- CLLS 0.03
- OZ -0.01
- Stochastic Oscillator
- CLLS 93.81
- OZ 53.01
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About OZ Belpointe PREP LLC Units
Belpointe PREP LLC is a qualified opportunity fund. The company's investments consist of properties located in qualified opportunity zones for the development or redevelopment of multifamily, student housing, senior living, healthcare, industrial, self-storage, hospitality, office, mixed-use, data centers, and solar projects located throughout the United States and its territories. Company currently has two reporting segments, commercial: includes properties such as office, retail centers, and warehouses; and mixed-use: includes properties that blend both residential and retail components within a single real estate asset.